Rate My Professor Randall Holcombe

Randall F. Holcombe, MD, MBA, is Professor of Medicine in the Division of Hematology/Oncology at the University of Vermont Larner College of Medicine, where he holds the J. Walter Juckett Chair in Cancer Research. He currently serves as Director of the University of Vermont Cancer Center, Associate Dean for Cancer Programs, Chief of the Division of Hematology/Oncology, and Director of Integrated Cancer Programs for the UVM Health Network. Dr. Holcombe earned a BA magna cum laude in Zoology and Chemistry from Duke University in 1979, an MD from the University of Medicine and Dentistry of New Jersey, New Jersey Medical School in 1983, and an MBA from the Zicklin School of Business at Baruch College in 2015. He completed residency and fellowship training in Internal Medicine and Hematology/Oncology at Brigham and Women's Hospital and Harvard Medical School. Board-certified in Internal Medicine, Hematology, and Medical Oncology, he practices as a GI oncologist.

Prior to joining the University of Vermont in August 2021, Dr. Holcombe directed the University of Hawai‘i Cancer Center from 2016 to 2021, securing over $47 million in grant funding and leading its National Cancer Institute redesignation. He previously served as Deputy Director of the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai from 2010 to 2016, Associate Director of Clinical and Translational Research at the Chao Family Comprehensive Cancer Center at the University of California, Irvine from 1997 to 2010, and in faculty positions at Louisiana State University School of Medicine from 1989 to 1997. As principal investigator for over 150 cancer clinical trials, his research focuses on health services and cancer care delivery science, particularly quality improvement and rural populations; Wnt signaling mechanisms in colon cancer promoting invasion and metastasis; and natural products including resveratrol and genistein for cancer prevention and treatment, supported by investigator-initiated trials such as NCT00256334, NCT00578396, and NCT01985763. Dr. Holcombe has served on editorial boards for Anti-Cancer Drugs, Cancer Management and Research, and Journal of Oncology Practice, and held leadership roles in the Association of American Cancer Institutes and National Community Oncology Research Program. He has received the Best Doctors in America recognition multiple years.